ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy

Huang, Linzhuo; Xu, Rui; Li, Weirong; Lv, Li; Lin, Chunhao; Yang, Xianzhu; Yao, Yandan; Saw, Phei Er*; Xu, Xiaoding*中山大学
Acta Biomaterialia2023-5DOI: 10.1016/j.actbio.2023.03.014
3被引18阅读
引用收藏
分享

摘要

Sorafenib is the first line drug for hepatocellular carcinoma (HCC) therapy. However, HCC patients usually acquire resistance to sorafenib treatment within 6 months. Recent evidences have shown that anticancer drugs with antiangiogenesis effect ( e.g. , soraf enib) can aggravate the hypoxia microenvironment and promote the infiltration of more tumor-associated macrophages (TAMs) into the tumor tissues. Therefore, repolarization of TAMs phenotype could be expected to not only eliminate the influence of TAMs on sorafenib lethality to HCC cells, but also provide an additional anticancer effect to achieve combination therapy. However, immune side effects remain a great challenge due to the non-specific macrophage repolarization in normal tissues. We herein employed a tumor microenvironment (TME) pH-responsive nanoplatform to concurrently transport sorafenib and modified resiquimod (R848-C16). This nanoparticle (NP) platform is made with a TME pH-responsive methoxyl-poly(ethylene glycol)- b -poly(lactic- co -glycolic acid) copolymer. After intravenous administration, the co-delivery NPs could highly accumulate in the tumor tissues and then respond to the TME pH to detach their surface PEG chains. With this PEG detachment to enhance uptake by TAMs and HCC cells, the co-delivery NPs could combinatorially inhibit HCC tumor growth via sorafenib-mediated lethality to HCC cells and R848-mediated repolarization of TAMs into tumoricidal M1-like macrophages.

学科与关键词

关键词
SorafenibTAMsNanoparticlesTME-responsiveCombination HCC therapy
相关
加载中…
  • CXCR4-guided liposomes regulating hypoxic and immunosuppressive microenvironment for sorafenib-resistant tumor treatment
    Wang, Yuehua; Wang, Zhenjie; Jia, Fei; Xu, Qing; Shu, Zhilin; Deng, Junlin; Li, Aimin*; Yu, Meng*; Yu, Zhiqiang*Bioactive Materials, 2022, 17: 147-161.被引 27
  • A polymeric nanoformulation improves the bioavailability and efficacy of sorafenib for hepatocellular carcinoma therapy
    Chen, Yang; Li, Jia-Xian; Shu, Na; Zheng, Sui-Juan; Ma, Min; Zhao, Zhi-Bin; Cao, Zhi-Ting*; Zhou, Qi*; Du, Jin-Zhi*; Wang, JunBiomaterials Science, 2021, 9(7): 2508-2518.被引 4
  • Nanoparticle-enabled concurrent modulation of phagocytosis and repolarization of macrophages for enhanced cancer immunotherapy
    Zhang, Jing-Yang; Chen, Fang -Man; Liu, Rong; Luo, Jia-Qi; Huang, Yong-Cong; Shu, Na; Zheng, Sui-Juan; Shao, Dan; Leong, Kam W.*; Du, Jin-Zhi*Nano Today, 2022, 47: 101651.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Acta Biomaterialia
发表日期
2023-05
卷期
第 162 卷
页码
98-109
DOI
10.1016/j.actbio.2023.03.014
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82173392, 81874226]; Thousand Talents Program for Distinguished Young Scholars; International Scientific and Technological Cooperation Program from Guangdong Science and Technology Department [2018A050506033]; Natural Science Foundation of Guangdong Province [2021A1515111106]; Guangzhou Science and Technology Bureau [201902020015, 20210303004]; "Three million for Three Years" Project of the High-level Talent Special Funding Scheme of Sun Yat-Sen Memorial Hospital

作者

  • H

    Huang, Linzhuo (第一作者)

    sun yat sen univ

  • X

    Xu, Rui

    sun yat sen univ

查看全部 9 位作者收起作者
  • L

    Li, Weirong

    sun yat sen univ

  • L

    Lv, Li

    sun yat sen univ

  • L

    Lin, Chunhao

    sun yat sen univ

  • Y

    Yang, Xianzhu

  • Y

    Yao, Yandan

    sun yat sen univ

  • S

    Saw, Phei Er (通讯)

    sun yat sen univ

  • X

    Xu, Xiaoding (通讯)

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417